BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+4.42%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$1.14B
AUM Growth
+$1.14B
(+11%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
11.49%
Top 10 Holdings %
Top 10 Hldgs %
48.07%
Holding
60
New
9
Increased
13
Reduced
15
Closed
3
Top Buys
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$31.3M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$24.6M |
| 3 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$17.6M |
| 4 |
AC Immune
ACIU
|
$16.1M |
| 5 |
Replimune Group
REPL
|
$14.7M |
Top Sells
| 1 |
Ironwood Pharmaceuticals
IRWD
|
$11.6M |
| 2 |
ARQL
Arqule Inc
ARQL
|
$9.17M |
| 3 |
AnaptysBio
ANAB
|
$8.48M |
| 4 |
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
|
$5.91M |
| 5 |
Forte Biosciences
FBRX
|
$4.4M |
Sector Composition
| 1 | Healthcare | 84.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $95.6M | 8.4% | 6,290,586 +1,618,391 | +35% | +$24.6M |
|
|
CCXI
2
DELISTED
ChemoCentryx, Inc.
CCXI
| $85.6M | 7.52% | 6,773,760 -260,586 | -4% | -$3.29M |
|
3
Merus
MRUS
$4.98B
| $77.3M | 6.79% | 3,914,913 | – | – |
|
4
Cytokinetics
CYTK
$4.23B
| $51.1M | 4.49% | 5,186,839 -364,051 | -7% | -$3.59M |
|
|
FPRX
5
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $47.1M | 4.14% | 3,381,117 +2,251,356 | +199% | +$31.3M |
|
|
BPMC
6
DELISTED
Blueprint Medicines
BPMC
| $46.7M | 4.1% | 598,267 -48,544 | -8% | -$3.79M |
|
|
INFI
7
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $41.3M | 3.63% | 15,232,268 | – | – |
|
8
Kura Oncology
KURA
$686M
| $35.3M | 3.1% | 2,015,856 -41,490 | -2% | -$726K |
|
|
MRTX
9
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $34.1M | 2.99% | 723,322 -21,678 | -3% | -$1.02M |
|
|
ARQL
10
DELISTED
Arqule Inc
ARQL
| $33M | 2.9% | 5,827,902 -1,620,010 | -22% | -$9.17M |
|
11
Xencor
XNCR
$580M
| $32.6M | 2.87% | 837,538 -32,107 | -4% | -$1.25M |
|
|
PVLA
12
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $31.4M | 2.76% | 5,600,521 +253,683 | +5% | +$1.42M |
|
|
BLRX
13
BioLineRX
BLRX
$16.2M
| $27.8M | 2.44% | 25,995,575 | – | – |
|
14
Protagonist Therapeutics
PTGX
$3.67B
| $26.9M | 2.37% | 2,617,967 +1,200,000 | +85% | +$12.3M |
|
15
Ionis Pharmaceuticals
IONS
$6.79B
| $26.8M | 2.36% | 520,000 -50,000 | -9% | -$2.58M |
|
16
Xoma
XOMA
$392M
| $26.4M | 2.32% | 1,502,800 | – | – |
|
|
17
AnaptysBio
ANAB
$569M
| $25M | 2.19% | 250,265 -85,000 | -25% | -$8.48M |
|
18
Galmed Pharmaceuticals
GLMD
$6.96M
| $23.9M | 2.1% | 1,761,567 | – | – |
|
|
CNCE
19
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $23.6M | 2.08% | 1,592,138 -225,000 | -12% | -$3.34M |
|
|
FWP
20
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $19.4M | 1.7% | 8,502,925 -500 | -0% | -$1.14K |
|
|
DRNA
21
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $17.6M | 1.54% | +1,152,073 | New | +$17.6M |
|
22
Corvus Pharmaceuticals
CRVS
$428M
| $16.2M | 1.43% | 1,890,507 | – | – |
|
|
23
AC Immune
ACIU
$205M
| $16.1M | 1.42% | +2,017,500 | New | +$16.1M |
|
|
IMDZ
24
DELISTED
Immune Design Corp.
IMDZ
| $16.1M | 1.41% | 4,658,353 +500,000 | +12% | +$1.72M |
|
25
Spero Therapeutics
SPRO
$116M
| $15.6M | 1.37% | 1,488,088 +439,130 | +42% | +$4.62M |
|